Full-Time

Sr Quality Specialist

Commercial Quality

Posted on 4/15/2025

Takeda

Takeda

10,001+ employees

Develops and commercializes biopharmaceuticals and vaccines

No salary listed

Senior

Noida, Uttar Pradesh, India

Category
QA & Testing
Quality Assurance
Requirements
  • Minimum 5 years’ experience in Pharmaceutical Company in quality function
  • Ability to work independently and identify compliance risks and escalate when necessary
  • Strong sense of urgency
  • Demonstrated interpersonal skills including strong negotiation skills
  • Excellent teamwork and coordination skills
  • Excellent verbal and writing skills and fluent in English and as applicable, local language is desired
Responsibilities
  • Execution of quality operations to ensure its compliance with local regulatory authority and Takeda’s global requirements for importation, local testing, product release, repackaging, storage and distribution of Takeda products
  • Local batch release activities including temperature records evaluation, ERP system release, documentation verification & review, coordinating with suppliers & origin sites for records availability, disposition of imported stock for local batch release
  • Maintaining all local procedures & processes of commercial Quality for redressing and local batch release and training of procedures to relevant stakeholders including suppliers
  • Performing product impact assessments & coordinating with global team & suppliers (if required) for stability assessments (as required) for commercial Quality products in India
  • As Quality Business Partner with local stakeholders, ensure quality support to local business projects and product launches are successful delivered in adherence to quality and regulatory compliance
  • Maintain redressing activity at LOC including process facilitation with supplier and disposition of redressed product by Takeda team. This includes (but not limited to) review & approval of redressing documents, redressing material approval request, additional supplier records as per supplier QMS, Takeda QMS records like deviation, change control, CAPA related to redressing, temperature records, disposition of redressed products
  • Maintenance of LOC QMS system and ensuring its KPI’s are met. This includes handling of applicable QMS elements (including but not limited to) Change control, deviations, CAPA, complaints, Risk mitigation, gap assessments etc for GxP activities
  • Maintain training management for local Quality procedures in Takeda LMS and assignment of it to identified target GxP audience (under the role of system training administrator)
  • Providing support during self-inspection, Takeda internal audits, supplier audit, any Regulatory inspection for LOC
  • Providing Quality oversight to supplier’s involved in GDP & GSP operations as per Quality agreement
  • Delegated quality operations to ensure compliance to Clinical Quality Assurance for local clinical operations (as back-up)

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines for patients. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline that includes 11 NMEs, with plans for up to 15 product launches by FY2024. Takeda's products are aimed at healthcare providers, hospitals, and patients around the world, and the company collaborates with about 41,000 suppliers to ensure the production and distribution of its medicines. Unlike many competitors, Takeda emphasizes patient-centric values, ensuring that the needs of patients guide its operations. Additionally, Takeda is committed to environmental sustainability, recognizing the connection between environmental health and human health. The company's goal is to provide life-changing treatments while also addressing environmental risks that could affect public health.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's focus on personalized medicine can increase treatment efficacy and patient satisfaction.
  • Expansion in Southeast Asia offers opportunities for increased market presence and revenue growth.
  • Collaborations with tech companies can accelerate R&D processes and reduce costs.

What critics are saying

  • Data breach could lead to financial and reputational damage for Takeda.
  • Antitrust litigation with Meijer may result in financial penalties or business practice changes.
  • High financial commitments in partnerships could strain resources if outcomes are not achieved.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations and R&D efforts.
  • Takeda's robust pipeline includes 11 NMEs with plans for 15 product launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

CyberNews
Apr 15th, 2025
Hackers want $75,000 for data allegedly stolen from Takeda

A new account on an illicit forum bearing the moniker "beltway" claims that in April 2025, it exported around two million rows of user information from Takeda.com.

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.

Pharmaceutical Technology
Feb 25th, 2025
Takeda broadens its deal with BridGene for up to $770m

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.